Scroll
To Top
Loading Events

« All Events

  • This event has passed.

Public Meeting on Patient-Focused Drug Development for Chronic Pain

July 9 @ 10:00 am - 4:00 pm

On July 9, 2018, FDA is hosting a public meeting on Patient-Focused Drug Development for Chronic Pain. FDA is interested in hearing patients’ perspectives on chronic pain, views on treatment approaches, and challenges or barriers to accessing treatments for chronic pain. FDA is particularly interested in hearing from patients who experience chronic pain that is managed with analgesic medications such as opioids, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants; other medications; and non-pharmacologic interventions or therapies.

The event will be broadcasted for those who are unable to attend in person.

Registration for the in-person meeting closes on Monday, July 2 and registration for the broadcast closes on Sunday, July 8.

More information.

Venue

FDA White Oak Campus
10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (rm. 1503)
Silver Spring, MD 20993 United States
+ Google Map
Phone:
(240) 402-6887